Molecular profiling currently offers no more than tumour morphology and basic immunohistochemistry.
about
Infrequent loss of luminal differentiation in ductal breast cancer metastasisNew breast cancer prognostic factors identified by computer-aided image analysis of HE stained histopathology imagesBreast cancer classification and prognostication through diverse systems along with recent emerging findings in this respect; the dawn of new perspectives in the clinical applications.Variation-preserving normalization unveils blind spots in gene expression profiling.Intrinsic subtypes from PAM50 gene expression assay in a population-based breast cancer cohort: differences by age, race, and tumor characteristics.FOXP3 transcription factor: a candidate marker for susceptibility and prognosis in triple negative breast cancerRevisiting the technical validation of tumour biomarker assays: how to open a Pandora's box.Multi-field-of-view strategy for image-based outcome prediction of multi-parametric estrogen receptor-positive breast cancer histopathology: Comparison to Oncotype DXMulti-field-of-view framework for distinguishing tumor grade in ER+ breast cancer from entire histopathology slides.Transcriptional shift identifies a set of genes driving breast cancer chemoresistanceGenes dysregulated to different extent or oppositely in estrogen receptor-positive and estrogen receptor-negative breast cancers.Prediction of outcome of early ER+ breast cancer is improved using a biomarker panel, which includes Ki-67 and p53.Microarrays in the 2010s: the contribution of microarray-based gene expression profiling to breast cancer classification, prognostication and prediction.Prognostic contribution of mammographic breast density and HER2 overexpression to the Nottingham Prognostic Index in patients with invasive breast cancerPrediction consistency and clinical presentations of breast cancer molecular subtypes for Han Chinese populationImmunoprofile from tissue microarrays to stratify familial breast cancer patientsMultigene Assays for Classification, Prognosis, and Prediction in Breast Cancer: a Critical Review on the Background and Clinical Utility.Molecular markers for breast cancer: prediction on tumor behavior.Pathological and molecular diagnosis of triple-negative breast cancer: a clinical perspective.Shear-wave elastography of invasive breast cancer: correlation between quantitative mean elasticity value and immunohistochemical profile.The histone chaperone HJURP is a new independent prognostic marker for luminal A breast carcinoma.Change in the microenvironment of breast cancer studied by FTIR imaging.The prognostic value of regulatory T cells infiltration in HER2-enriched breast cancer microenvironment.VEGF and TWIST1 in a 16-biomarker immunoprofile useful for prognosis of breast cancer patients.Androgen Receptor Expression in Breast Cancer: What Differences Between Primary Tumor and Metastases?
P2860
Q28534555-CB4E9C23-FE71-491D-999F-0E83214784F1Q28646873-F34DFB1B-EC8E-4415-8B4A-7422F0951ED0Q30245184-B7139A75-654E-45C7-9705-9815055E1591Q30841312-81617CBA-81AB-465D-A787-6B88E2042E21Q33573884-4176A8B9-2971-4B53-B21A-34FD48EA788DQ33616070-459E0DF5-3F40-4624-A281-9BD9E461C82AQ33876854-8C327D6A-3061-4F64-923E-E9116D612647Q34289056-F91CA101-0E43-42F8-847B-D013270C54D5Q34326799-E9949EA2-9258-498D-A9C5-233AD09DFA5BQ34552025-51D18D44-99BE-422D-BC4D-06FB1CC497FDQ34854816-4F8631A4-AA79-4FA8-8EC2-DCA45C4EE5FAQ35125648-1A3F76BB-56D6-4807-901E-3AECB6A296E2Q35558070-D9601748-F009-4B10-A5B2-E04DE799B634Q36180689-B8F1080B-C237-4287-BCB0-EBB003683C68Q36244030-39706D6B-33E4-4025-8E04-6C616EDB27AEQ36413928-675D9C9E-3ADE-4CA8-B904-CFF97849BBB8Q37383276-7738FA38-1BFB-44C9-BB87-095E2748B845Q37586753-28044DB0-F695-400C-9182-A470982490E1Q38046575-80414AB3-D3CF-4D03-8E21-C4B7A9152802Q38074549-7931CAB6-A191-4333-BC16-C358B1E99852Q38302260-F414E9BB-E877-4849-B05C-06D71BBC43F9Q39421353-31A0B895-97AC-4D17-A31B-A158B09CB5E7Q48093934-61FDB62F-B716-4C89-950F-ED664CA21EF7Q48177300-77728234-22DE-4031-A583-4E0D48C7E579Q55709334-8D8CD259-9F56-4AA5-890A-11BBD7E2E75A
P2860
Molecular profiling currently offers no more than tumour morphology and basic immunohistochemistry.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Molecular profiling currently ...... nd basic immunohistochemistry.
@ast
Molecular profiling currently ...... nd basic immunohistochemistry.
@en
Molecular profiling currently ...... nd basic immunohistochemistry.
@nl
type
label
Molecular profiling currently ...... nd basic immunohistochemistry.
@ast
Molecular profiling currently ...... nd basic immunohistochemistry.
@en
Molecular profiling currently ...... nd basic immunohistochemistry.
@nl
prefLabel
Molecular profiling currently ...... nd basic immunohistochemistry.
@ast
Molecular profiling currently ...... nd basic immunohistochemistry.
@en
Molecular profiling currently ...... nd basic immunohistochemistry.
@nl
P2860
P356
P1476
Molecular profiling currently ...... nd basic immunohistochemistry.
@en
P2860
P2888
P356
10.1186/BCR2734
P478
12 Suppl 4
P577
2010-12-20T00:00:00Z
P5875
P6179
1011523662